Peregrine Asset Advisers Inc. Invests $663,000 in UnitedHealth Group Incorporated (UNH) Stock

Peregrine Asset Advisers Inc. bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor bought 3,573 shares of the healthcare conglomerate’s stock, valued at approximately $663,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Regal Wealth Group Inc. increased its stake in UnitedHealth Group by 0.4% during the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after buying an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. increased its stake in UnitedHealth Group by 0.4% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after buying an additional 4 shares during the period. RB Capital Management LLC increased its stake in UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after buying an additional 7 shares during the period. Altfest L J & Co. Inc. increased its stake in UnitedHealth Group by 0.3% during the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after buying an additional 10 shares during the period. Finally, Parkside Financial Bank & Trust increased its stake in UnitedHealth Group by 1.4% during the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 12 shares during the period. 86.00% of the stock is currently owned by hedge funds and other institutional investors.

Several equities research analysts recently weighed in on UNH shares. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price on the stock in a research note on Thursday, September 21st. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Cantor Fitzgerald reissued a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, August 29th. Jefferies Group LLC reissued a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a research report on Friday, August 18th. Finally, Leerink Swann reissued a “buy” rating and issued a $240.00 price objective (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $216.65.

ILLEGAL ACTIVITY WARNING: “Peregrine Asset Advisers Inc. Invests $663,000 in UnitedHealth Group Incorporated (UNH) Stock” was originally posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://sportsperspectives.com/2017/11/19/peregrine-asset-advisers-inc-invests-663000-in-unitedhealth-group-incorporated-unh-stock.html.

In related news, Director Gail R. Wilensky sold 5,600 shares of the stock in a transaction on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total transaction of $1,117,144.00. Following the completion of the sale, the director now owns 60,834 shares in the company, valued at approximately $12,135,774.66. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The disclosure for this sale can be found here. In the last quarter, insiders have sold 72,606 shares of company stock valued at $14,308,783. 0.89% of the stock is owned by company insiders.

Shares of UnitedHealth Group Incorporated (NYSE:UNH) opened at $209.90 on Friday. The firm has a market cap of $204,130.00, a price-to-earnings ratio of 22.05, a P/E/G ratio of 1.57 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. UnitedHealth Group Incorporated has a 52 week low of $148.56 and a 52 week high of $213.93.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The firm had revenue of $50.32 billion during the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.17 EPS. analysts forecast that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be paid a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.43%. The ex-dividend date is Thursday, November 30th. UnitedHealth Group’s dividend payout ratio is currently 34.09%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply